Johnson & Johnson May Never Recoup Its Costs to Buy Actelion
It's also, like every other company on planet Earth, not absolved from making a mistake from time to time. in an all-cash deal, which will be funded by some of J&J's cash hoard currently being held outside the United States.
from Biotech News
0 Comments